Raab & Moskowitz Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$757K Hold
1,701
0.18% 102
2025
Q1
$825K Hold
1,701
0.21% 94
2024
Q4
$685K Sell
1,701
-48
-3% -$19.3K 0.17% 103
2024
Q3
$813K Sell
1,749
-37
-2% -$17.2K 0.21% 93
2024
Q2
$837K Buy
1,786
+48
+3% +$22.5K 0.23% 87
2024
Q1
$727K Hold
1,738
0.2% 95
2023
Q4
$707K Sell
1,738
-27
-2% -$11K 0.22% 93
2023
Q3
$614K Hold
1,765
0.22% 95
2023
Q2
$621K Hold
1,765
0.21% 94
2023
Q1
$556K Sell
1,765
-58
-3% -$18.3K 0.2% 98
2022
Q4
$526K Buy
1,823
+125
+7% +$36.1K 0.2% 101
2022
Q3
$491K Sell
1,698
-5
-0.3% -$1.45K 0.21% 101
2022
Q2
$479K Hold
1,703
0.19% 111
2022
Q1
$444K Buy
1,703
+50
+3% +$13K 0.15% 118
2021
Q4
$363K Hold
1,653
0.12% 129
2021
Q3
$300K Hold
1,653
0.11% 137
2021
Q2
$333K Hold
1,653
0.12% 130
2021
Q1
$355K Buy
1,653
+15
+0.9% +$3.22K 0.14% 115
2020
Q4
$387K Sell
1,638
-6
-0.4% -$1.42K 0.16% 111
2020
Q3
$447K Buy
1,644
+4
+0.2% +$1.09K 0.21% 99
2020
Q2
$476K Sell
1,640
-28
-2% -$8.13K 0.23% 95
2020
Q1
$396K Hold
1,668
0.22% 98
2019
Q4
$365K Hold
1,668
0.14% 122
2019
Q3
$282K Hold
1,668
0.12% 135
2019
Q2
$305K Hold
1,668
0.14% 132
2019
Q1
$306K Hold
1,668
0.14% 130
2018
Q4
$276K Hold
1,668
0.14% 130
2018
Q3
$321K Hold
1,668
0.13% 129
2018
Q2
$283K Hold
1,668
0.14% 129
2018
Q1
$271K Buy
+1,668
New +$271K 0.13% 130